Aktie A3E2GE INSTIL BIO, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Instil Bio, Inc.

Aktien

A3E2GE

US45783C2008

TIL

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:00 26.04.2024 		% 5 Tage % 1. Jan.
10,6 USD +1,92 % Intraday Chart für Instil Bio, Inc. -0,38 % +39,11 %
26.04. Instil Bio, Inc. kündigt Änderungen im Vorstand an CI
12.04. INSTIL BIO, INC. : Jefferies & Co. ist jetzt neutral ZM

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Instil Bio, Inc. Announces Board Changes
North American Morning Briefing : Stock Futures -2-
Instil Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Instil Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Instil Bio Announces Strategic Update
Instil Bio, Inc. Enters into Agreement with A Collaboration to Conduct Preclinical Manufacturing Feasibility Studies in the ITIL-306 Program
Instil Bio, Inc. Announces the Closure of Its UK Manufacturing and Clinical Operations
Instil Bio, Inc.(NasdaqCM:TIL) dropped from NASDAQ Biotechnology Index
Instil Bio Says 1-for-20 Reverse Stock Split to Take Effect on Dec. 7
Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split
Instil Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting
Instil Bio, Inc.(NasdaqCM:TIL) dropped from S&P Global BMI Index
Instil Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference
Instil Bio, Inc. Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference
Instil Bio, Inc.(NasdaqGS:TIL) dropped from Russell Small Cap Comp Value Index
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3E2GE Aktie
  4. Nachrichten Instil Bio, Inc.
  5. Andere Sprachen